{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:51:43Z","timestamp":1783021903202,"version":"3.54.6"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Internal Foundation of Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University","award":["2023JCYJYB136"],"award-info":[{"award-number":["2023JCYJYB136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37428-8","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:24:51Z","timestamp":1769930691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating network toxicology, machine learning, and molecular dynamics simulations to reveal tanshinone iia\u2019s dual mechanisms in TNBC and doxorubicin-induced cardiotoxicity"],"prefix":"10.1038","volume":"16","author":[{"given":"Bo","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-chen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"issue":"1","key":"37428_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin Jan-Feb. 75 (1), 10\u201345. https:\/\/doi.org\/10.3322\/caac.21871 (2025).","journal-title":"CA Cancer J. Clin Jan-Feb"},{"issue":"12","key":"37428_CR2","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1200\/JCO.1991.9.12.2134","volume":"9","author":"R Buzzoni","year":"1991","unstructured":"Buzzoni, R., Bonadonna, G., Valagussa, P. & Zambetti, M. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. J Clin. Oncol Dec. 9 (12), 2134\u20132140. https:\/\/doi.org\/10.1200\/JCO.1991.9.12.2134 (1991).","journal-title":"J Clin. Oncol Dec."},{"issue":"5","key":"37428_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nm.4087","volume":"22","author":"PW Burridge","year":"2016","unstructured":"Burridge, P. W. et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med May. 22 (5), 547\u2013556. https:\/\/doi.org\/10.1038\/nm.4087 (2016).","journal-title":"Nat Med May"},{"issue":"4","key":"37428_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12012-022-09721-1","volume":"22","author":"M Sheibani","year":"2022","unstructured":"Sheibani, M. et al. Doxorubicin-Induced cardiotoxicity: an overview on Pre-clinical therapeutic approaches. Cardiovasc Toxicol Apr. 22 (4), 292\u2013310. https:\/\/doi.org\/10.1007\/s12012-022-09721-1 (2022).","journal-title":"Cardiovasc Toxicol Apr"},{"key":"37428_CR5","doi-asserted-by":"publisher","first-page":"153473542311646","DOI":"10.1177\/15347354231164621","volume":"22","author":"Y Shi","year":"2023","unstructured":"Shi, Y. et al. Extract of platycodon grandiflorum prevents Doxorubicin-induced cardiotoxicity in breast cancer. Integr Cancer Ther Jan-Dec. 22, 15347354231164621. https:\/\/doi.org\/10.1177\/15347354231164621 (2023).","journal-title":"Integr Cancer Ther Jan-Dec"},{"key":"37428_CR6","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.2147\/DDDT.S266911","volume":"14","author":"R Guo","year":"2020","unstructured":"Guo, R. et al. Pharmacological activity and mechanism of Tanshinone IIA in related diseases. Drug Des. Devel Ther. 14, 4735\u20134748. https:\/\/doi.org\/10.2147\/DDDT.S266911 (2020).","journal-title":"Drug Des. Devel Ther."},{"issue":"6","key":"37428_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/kjm2.12663","volume":"39","author":"W Li","year":"2023","unstructured":"Li, W., Gao, Z. & Guan, Q. L. Tan IIA mitigates vascular smooth muscle cell proliferation and migration induced by ox-LDL through the miR-137\/TRPC3 axis. Kaohsiung J. Med. Sci Jun. 39 (6), 596\u2013604. https:\/\/doi.org\/10.1002\/kjm2.12663 (2023).","journal-title":"Kaohsiung J. Med. Sci Jun"},{"key":"37428_CR8","doi-asserted-by":"publisher","first-page":"154439","DOI":"10.1016\/j.phymed.2022.154439","volume":"106","author":"Q Jiang","year":"2022","unstructured":"Jiang, Q. et al. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway. Phytomedicine Nov. 106, 154439. https:\/\/doi.org\/10.1016\/j.phymed.2022.154439 (2022).","journal-title":"Phytomedicine Nov"},{"issue":"6","key":"37428_CR9","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/ptr.6353","volume":"33","author":"K Li","year":"2019","unstructured":"Li, K. et al. Combination of Tanshinone IIA and doxorubicin possesses synergism and Attenuation effects on doxorubicin in the treatment of breast cancer. Phytother Res Jun. 33 (6), 1658\u20131669. https:\/\/doi.org\/10.1002\/ptr.6353 (2019).","journal-title":"Phytother Res Jun"},{"issue":"8","key":"37428_CR10","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1039\/d2bm00526c","volume":"11","author":"M Li","year":"2023","unstructured":"Li, M. et al. STS loaded PCL-MECM based hydrogel hybrid scaffolds promote meniscal regeneration via modulating macrophage phenotype polarization. Biomater Sci Apr. 11 (8), 2759\u20132774. https:\/\/doi.org\/10.1039\/d2bm00526c (2023).","journal-title":"Biomater Sci Apr"},{"issue":"9","key":"37428_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12032-025-02968-y","volume":"9","author":"Q Liu","year":"2025","unstructured":"Liu, Q. et al. Tanshinone IIA is synergistic with the PARP inhibitor Olaparib in inducing BRCAs-proficient and -deficient triple-negative breast cancer cell apoptosis. Med Oncol Aug. 9 (9), 419. https:\/\/doi.org\/10.1007\/s12032-025-02968-y (2025).","journal-title":"Med Oncol Aug"},{"issue":"2","key":"37428_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3892\/etm.2022.11449","volume":"24","author":"W Mao","year":"2022","unstructured":"Mao, W., Ding, J., Li, Y., Huang, R. & Wang, B. Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma. Exp Ther. Med Aug. 24 (2), 521. https:\/\/doi.org\/10.3892\/etm.2022.11449 (2022).","journal-title":"Exp Ther. Med Aug"},{"issue":"1","key":"37428_CR13","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/nar\/gkae1059","volume":"6","author":"S Kim","year":"2025","unstructured":"Kim, S. et al. PubChem 2025 update. Nucleic Acids Res Jan. 6 (1), 1516\u20131525. https:\/\/doi.org\/10.1093\/nar\/gkae1059 (2025).","journal-title":"Nucleic Acids Res Jan"},{"issue":"Pt A","key":"37428_CR14","doi-asserted-by":"publisher","first-page":"115876","DOI":"10.1016\/j.jep.2022.115876","volume":"10","author":"L Shang","year":"2023","unstructured":"Shang, L. et al. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network Pharmacology and experimental validation. J Ethnopharmacol Feb. 10 (Pt A), 115876. https:\/\/doi.org\/10.1016\/j.jep.2022.115876 (2023).","journal-title":"J Ethnopharmacol Feb"},{"issue":"1","key":"37428_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/nar\/gkad976","volume":"5","author":"C Knox","year":"2024","unstructured":"Knox, C. et al. DrugBank 6.0: the drugbank knowledgebase for 2024. Nucleic Acids Res Jan. 5 (1), 1265\u20131275. https:\/\/doi.org\/10.1093\/nar\/gkad976 (2024).","journal-title":"Nucleic Acids Res Jan"},{"issue":"1","key":"37428_CR16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/nar\/gkv1165","volume":"4","author":"AH Wagner","year":"2016","unstructured":"Wagner, A. H. et al. DGIdb 2.0: mining clinically relevant drug-gene interactions. Nucleic Acids Res Jan. 4 (1), 1036\u20131044. https:\/\/doi.org\/10.1093\/nar\/gkv1165 (2016).","journal-title":"Nucleic Acids Res Jan"},{"issue":"10000","key":"37428_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S0140-6736(15)60459-7","volume":"26","author":"EB Deerenberg","year":"2015","unstructured":"Deerenberg, E. B. et al. Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet Sep. 26 (10000), 1254\u20131260. https:\/\/doi.org\/10.1016\/S0140-6736(15)60459-7 (2015).","journal-title":"Lancet Sep."},{"key":"37428_CR18","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.csbj.2021.05.015","volume":"19","author":"J Pinero","year":"2021","unstructured":"Pinero, J., Sauch, J., Sanz, F. & Furlong, L. I. The disgenet cytoscape app: exploring and visualizing disease genomics data. Comput. Struct. Biotechnol. J. 19, 2960\u20132967. https:\/\/doi.org\/10.1016\/j.csbj.2021.05.015 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"37428_CR19","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/nar\/gkac833","volume":"6","author":"AP Davis","year":"2023","unstructured":"Davis, A. P. et al. Comparative toxicogenomics database (CTD): update 2023. Nucleic Acids Res Jan. 6 (1), 1257\u20131262. https:\/\/doi.org\/10.1093\/nar\/gkac833 (2023).","journal-title":"Nucleic Acids Res Jan"},{"key":"37428_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"20","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc. Bioinformatics Jun. 20, 54:1\u201333. https:\/\/doi.org\/10.1002\/cpbi.5 (2016).","journal-title":"Curr Protoc. Bioinformatics Jun"},{"issue":"11","key":"37428_CR21","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1002\/ajmg.a.62407","volume":"185","author":"A Hamosh","year":"2021","unstructured":"Hamosh, A., Amberger, J. S., Bocchini, C., Scott, A. F. & Rasmussen, S. A. Online Mendelian inheritance in man (OMIM(R)): victor mckusick\u2019s magnum opus. Am J. Med. Genet. A Nov. 185 (11), 3259\u20133265. https:\/\/doi.org\/10.1002\/ajmg.a.62407 (2021).","journal-title":"Am J. Med. Genet. A Nov"},{"key":"37428_CR22","doi-asserted-by":"publisher","first-page":"1102581","DOI":"10.3389\/fphar.2023.1102581","volume":"14","author":"Q He","year":"2023","unstructured":"He, Q. et al. Exploring the mechanism of Curcumin in the treatment of colon cancer based on network Pharmacology and molecular Docking. Front. Pharmacol. 14, 1102581. https:\/\/doi.org\/10.3389\/fphar.2023.1102581 (2023).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"37428_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/nar\/gkac1000","volume":"6","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res Jan. 6 (1), 638\u2013646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res Jan"},{"key":"37428_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/JIR.S489827","volume":"18","author":"Q Li","year":"2025","unstructured":"Li, Q. et al. Integrated analysis and validation of Ferroptosis-Related genes associated with Ischemia\/Reperfusion injury in lung transplantation. J. Inflamm. Res. 18, 251\u2013270. https:\/\/doi.org\/10.2147\/JIR.S489827 (2025).","journal-title":"J. Inflamm. Res."},{"issue":"9","key":"37428_CR25","doi-asserted-by":"publisher","first-page":"e0184129","DOI":"10.1371\/journal.pone.0184129","volume":"12","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLoS One. 12 (9), e0184129. https:\/\/doi.org\/10.1371\/journal.pone.0184129 (2017).","journal-title":"PLoS One"},{"issue":"1","key":"37428_CR26","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"3","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun Apr. 3 (1), 1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6 (2019).","journal-title":"Nat Commun Apr"},{"key":"37428_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","volume":"1607","author":"SK Burley","year":"2017","unstructured":"Burley, S. K. et al. Protein data bank (PDB): the single global macromolecular structure archive. Methods Mol. Biol. 1607, 627\u2013641. https:\/\/doi.org\/10.1007\/978-1-4939-7000-1_26 (2017).","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"37428_CR28","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"23","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F., Forli, S. & AutoDock Vina 1.2.0: new Docking Methods, expanded force Field, and python bindings. J Chem. Inf. Model Aug. 23 (8), 3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203 (2021).","journal-title":"J Chem. Inf. Model Aug"},{"key":"37428_CR29","doi-asserted-by":"publisher","first-page":"baad062","DOI":"10.1093\/database\/baad062","volume":"13","author":"S Rampogu","year":"2023","unstructured":"Rampogu, S. et al. CBPDdb: a curated database of compounds derived from Coumarin-Benzothiazole-Pyrazole. Database (Oxford) Sep. 13, 2023:baad062. https:\/\/doi.org\/10.1093\/database\/baad062 (2023).","journal-title":"Database (Oxford) Sep."},{"key":"37428_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-4939-7366-8_4","volume":"1685","author":"H Land","year":"2018","unstructured":"Land, H. & Humble, M. S. YASARA: A tool to obtain structural guidance in biocatalytic investigations. Methods Mol. Biol. 1685, 43\u201367. https:\/\/doi.org\/10.1007\/978-1-4939-7366-8_4 (2018).","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"37428_CR31","doi-asserted-by":"publisher","first-page":"e2140","DOI":"10.52225\/narra.v5i2.2140","volume":"5","author":"B Oktomalioputri","year":"2025","unstructured":"Oktomalioputri, B., Afriwardi, A., Darwin, E. & Rita, R. S. Network pharmacology, molecular docking, and molecular dynamics analyses to explore the molecular mechanism of Paclitaxel in atherosclerosis therapy. Narra J Aug. 5 (2), e2140. https:\/\/doi.org\/10.52225\/narra.v5i2.2140 (2025).","journal-title":"Narra J Aug"},{"key":"37428_CR32","doi-asserted-by":"publisher","unstructured":"Chen, G. et al. Restructured GEO: restructuring Gene Expression Omnibus metadata for genome dynamics analysis. Database (Oxford). Jan 1 2019;2019:bay145. https:\/\/doi.org\/10.1093\/database\/bay145","DOI":"10.1093\/database\/bay145"},{"issue":"4","key":"37428_CR33","doi-asserted-by":"publisher","first-page":"046107","DOI":"10.1063\/5.0233961","volume":"8","author":"HJ Lo","year":"2024","unstructured":"Lo, H. J., Tsai, C. H. & Huang, T. W. Apoptosis-associated genetic mechanisms in the transition from rheumatoid arthritis to osteoporosis: A bioinformatics and functional analysis approach. APL Bioeng Dec. 8 (4), 046107. https:\/\/doi.org\/10.1063\/5.0233961 (2024).","journal-title":"APL Bioeng Dec."},{"key":"37428_CR34","doi-asserted-by":"publisher","first-page":"156892","DOI":"10.1016\/j.phymed.2025.156892","volume":"25","author":"G Chen","year":"2025","unstructured":"Chen, G. et al. Predicting the molecular mechanism of ginger targeting PRMT1\/BTG2 axis to inhibit gastric cancer based on WGCNA and machine algorithms. Phytomedicine Jul. 25, 143:156892. https:\/\/doi.org\/10.1016\/j.phymed.2025.156892 (2025).","journal-title":"Phytomedicine Jul"},{"issue":"1","key":"37428_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ana.26370","volume":"92","author":"G Bose","year":"2022","unstructured":"Bose, G. et al. Early predictors of clinical and MRI outcomes using least absolute shrinkage and selection operator (LASSO) in multiple sclerosis. Ann Neurol Jul. 92 (1), 87\u201396. https:\/\/doi.org\/10.1002\/ana.26370 (2022).","journal-title":"Ann Neurol Jul"},{"issue":"1","key":"37428_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11658-024-00536-2","volume":"30","author":"Y Li","year":"2024","unstructured":"Li, Y., Yu, J., Li, R., Zhou, H. & Chang, X. New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation. Cell Mol. Biol. Lett Jan. 30 (1), 21. https:\/\/doi.org\/10.1186\/s11658-024-00536-2 (2024).","journal-title":"Cell Mol. Biol. Lett Jan"},{"issue":"1","key":"37428_CR37","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1038\/s41598-023-33327-4","volume":"19","author":"NS Maurya","year":"2023","unstructured":"Maurya, N. S., Kushwah, S., Kushwaha, S., Chawade, A. & Mani, A. Prognostic model development for classification of colorectal adenocarcinoma by using machine learning model based on feature selection technique Boruta. Sci Rep Apr. 19 (1), 6413. https:\/\/doi.org\/10.1038\/s41598-023-33327-4 (2023).","journal-title":"Sci Rep Apr"},{"issue":"9","key":"37428_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan, W. M. & Ricketts, C. J. The cancer genome atlas of renal cell carcinoma: findings and clinical implications. Nat Rev. Urol Sep. 16 (9), 539\u2013552. https:\/\/doi.org\/10.1038\/s41585-019-0211-5 (2019).","journal-title":"Nat Rev. Urol Sep."},{"issue":"7","key":"37428_CR39","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.21037\/tcr-24-201","volume":"31","author":"W Zheng","year":"2024","unstructured":"Zheng, W. et al. Systematic analysis of TREM2 and its carcinogenesis in pancreatic cancer. Transl Cancer Res Jul. 31 (7), 3200\u20133216. https:\/\/doi.org\/10.21037\/tcr-24-201 (2024).","journal-title":"Transl Cancer Res Jul"},{"key":"37428_CR40","doi-asserted-by":"publisher","first-page":"870726","DOI":"10.3389\/fimmu.2022.870726","volume":"13","author":"X Liang","year":"2022","unstructured":"Liang, X., Li, L., Fan, Y. & Diagnostic Prognostic, and immunological roles of HELLS in Pan-Cancer: A bioinformatics analysis. Front. Immunol. 13, 870726. https:\/\/doi.org\/10.3389\/fimmu.2022.870726 (2022).","journal-title":"Front. Immunol."},{"key":"37428_CR41","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.2147\/IJN.S473052","volume":"19","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Combined photothermal chemotherapy for effective treatment against breast cancer in mice model. Int. J. Nanomed. 19, 9973\u20139987. https:\/\/doi.org\/10.2147\/IJN.S473052 (2024).","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"37428_CR42","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/14737140.2017.1347505","volume":"17","author":"EC Aniogo","year":"2017","unstructured":"Aniogo, E. C., George, B. P. A. & Abrahamse, H. Phthalocyanine induced phototherapy coupled with Doxorubicin; a promising novel treatment for breast cancer. Expert Rev. Anticancer Ther Aug. 17 (8), 693\u2013702. https:\/\/doi.org\/10.1080\/14737140.2017.1347505 (2017).","journal-title":"Expert Rev. Anticancer Ther Aug"},{"issue":"6","key":"37428_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1208\/s12249-020-01743-8","volume":"21","author":"N Chowdhury","year":"2020","unstructured":"Chowdhury, N. et al. Targeted delivery of doxorubicin liposomes for Her-2\u2009+\u2009Breast cancer treatment. AAPS PharmSciTech Jul. 21 (6), 202. https:\/\/doi.org\/10.1208\/s12249-020-01743-8 (2020).","journal-title":"AAPS PharmSciTech Jul"},{"key":"37428_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.lfs.2018.03.023","volume":"200","author":"A Pugazhendhi","year":"2018","unstructured":"Pugazhendhi, A., Edison, T., Velmurugan, B. K., Jacob, J. A. & Karuppusamy, I. Toxicity of doxorubicin (Dox) to different experimental organ systems. Life Sci May 1. 200, 26\u201330. https:\/\/doi.org\/10.1016\/j.lfs.2018.03.023 (2018).","journal-title":"Life Sci May 1"},{"key":"37428_CR45","doi-asserted-by":"publisher","first-page":"120701","DOI":"10.1016\/j.lfs.2022.120701","volume":"1","author":"F Maleki","year":"2022","unstructured":"Maleki, F., Salimi, M., Shirkoohi, R. & Rezaei, M. Mitotherapy in doxorubicin induced cardiotoxicity: A promising strategy to reduce the complications of treatment. Life Sci Sep. 1, 304:120701. https:\/\/doi.org\/10.1016\/j.lfs.2022.120701 (2022).","journal-title":"Life Sci Sep."},{"key":"37428_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.biopha.2018.02.055","volume":"100","author":"S Li","year":"2018","unstructured":"Li, S. et al. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. Biomed Pharmacother Apr. 100, 441\u2013447. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.055 (2018).","journal-title":"Biomed Pharmacother Apr"},{"issue":"7","key":"37428_CR47","doi-asserted-by":"publisher","first-page":"EVIDe2300124","DOI":"10.1056\/EVIDe2300124","volume":"2","author":"T Liu","year":"2023","unstructured":"Liu, T. Potential benefits and risks of interim analyses in clinical studies. NEJM Evid Jul. 2 (7), EVIDe2300124. https:\/\/doi.org\/10.1056\/EVIDe2300124 (2023).","journal-title":"NEJM Evid Jul"},{"issue":"1","key":"37428_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s13346-024-01648-0","volume":"15","author":"A Bisht","year":"2025","unstructured":"Bisht, A. et al. A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer. Drug Deliv Transl Res Jan. 15 (1), 102\u2013133. https:\/\/doi.org\/10.1007\/s13346-024-01648-0 (2025).","journal-title":"Drug Deliv Transl Res Jan"},{"issue":"2","key":"37428_CR49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12012-024-09952-4","volume":"25","author":"B Buchalska","year":"2025","unstructured":"Buchalska, B., Kaminska, K., Kowara, M., Sobiborowicz-Sadowska, A. & Cudnoch-Jedrzejewska, A. Doxorubicin or epirubicin versus liposomal doxorubicin Therapy-Differences in cardiotoxicity. Cardiovasc Toxicol Feb. 25 (2), 248\u2013268. https:\/\/doi.org\/10.1007\/s12012-024-09952-4 (2025).","journal-title":"Cardiovasc Toxicol Feb"},{"key":"37428_CR50","doi-asserted-by":"publisher","first-page":"108599","DOI":"10.1016\/j.biopha.2019.108599","volume":"112","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs\/mTOR-dependent autophagy pathway. Biomed Pharmacother Apr. 112, 108599. https:\/\/doi.org\/10.1016\/j.biopha.2019.108599 (2019).","journal-title":"Biomed Pharmacother Apr"},{"issue":"16","key":"37428_CR51","doi-asserted-by":"publisher","first-page":"e30862","DOI":"10.7554\/eLife.30862","volume":"16","author":"AM Halstead","year":"2017","unstructured":"Halstead, A. M. et al. Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation. Elife Nov. 16 (16), e30862. https:\/\/doi.org\/10.7554\/eLife.30862 (2017).","journal-title":"Elife Nov"},{"key":"37428_CR52","doi-asserted-by":"publisher","unstructured":"Tsai, J. M. et al. UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability. Mol Cell. Aug 3. ;83(15):2753\u20132767. (2023). https:\/\/doi.org\/10.1016\/j.molcel.2023.06.028","DOI":"10.1016\/j.molcel.2023.06.028"},{"issue":"7964","key":"37428_CR53","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41586-023-06068-7","volume":"618","author":"A Paredes","year":"2023","unstructured":"Paredes, A. et al. gamma-Linolenic acid in maternal milk drives cardiac metabolic maturation. Nature Jun. 618 (7964), 365\u2013373. https:\/\/doi.org\/10.1038\/s41586-023-06068-7 (2023).","journal-title":"Nature Jun"},{"issue":"6","key":"37428_CR54","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/jcp.23005","volume":"227","author":"AB Singh","year":"2012","unstructured":"Singh, A. B., Guleria, R. S., Nizamutdinova, I. T., Baker, K. M. & Pan, J. High glucose-induced repression of RAR\/RXR in cardiomyocytes is mediated through oxidative stress\/JNK signaling. J Cell. Physiol Jun. 227 (6), 2632\u20132644. https:\/\/doi.org\/10.1002\/jcp.23005 (2012).","journal-title":"J Cell. Physiol Jun"},{"issue":"2","key":"37428_CR55","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","volume":"22","author":"M Cagel","year":"2017","unstructured":"Cagel, M., Grotz, E., Bernabeu, E., Moretton, M. A. & Chiappetta, D. A. Doxorubicin: Nanotechnological overviews from bench to bedside. Drug Discov Today Feb. 22 (2), 270\u2013281. https:\/\/doi.org\/10.1016\/j.drudis.2016.11.005 (2017).","journal-title":"Drug Discov Today Feb"},{"issue":"5","key":"37428_CR56","doi-asserted-by":"publisher","first-page":"eaay2939","DOI":"10.1126\/sciadv.aay2939","volume":"6","author":"X Ma","year":"2020","unstructured":"Ma, X. et al. Retinoid X receptor alpha is a Spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity. Sci Adv Jan. 6 (5), eaay2939. https:\/\/doi.org\/10.1126\/sciadv.aay2939 (2020).","journal-title":"Sci Adv Jan"},{"issue":"7","key":"37428_CR57","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.3390\/ijms26073034","volume":"26","author":"HH Yuan","year":"2025","unstructured":"Yuan, H. H. et al. From DNA repair to redox signaling: the multifaceted role of APEX1 (Apurinic\/Apyrimidinic endonuclease 1) in cardiovascular health and disease. Int J. Mol. Sci Mar. 26 (7), 3034. https:\/\/doi.org\/10.3390\/ijms26073034 (2025).","journal-title":"Int J. Mol. Sci Mar."},{"issue":"5","key":"37428_CR58","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1007\/s10528-024-10926-y","volume":"24","author":"F Lu","year":"2025","unstructured":"Lu, F., Ding, L. & Qiao, Y. APEX1 knockdown alleviates inflammation and fibrosis in myocardial infarction through promoting ZCCHC9 expression and blocking the p38 MAPK signaling. Biochem Genet Oct. 24 (5), 4566. https:\/\/doi.org\/10.1007\/s10528-024-10926-y (2025).","journal-title":"Biochem Genet Oct."},{"issue":"1","key":"37428_CR59","doi-asserted-by":"publisher","first-page":"13867","DOI":"10.1038\/s41598-017-10131-5","volume":"24","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Screening and identification of critical transcription factors involved in the protection of cardiomyocytes against hydrogen peroxide-induced damage by Yixin-shu. Sci Rep Oct. 24 (1), 13867. https:\/\/doi.org\/10.1038\/s41598-017-10131-5 (2017).","journal-title":"Sci Rep Oct."},{"key":"37428_CR60","doi-asserted-by":"publisher","first-page":"101970","DOI":"10.1016\/j.redox.2021.101970","volume":"43","author":"K Sriramajayam","year":"2021","unstructured":"Sriramajayam, K. et al. Activation of NRF2 by APE1\/REF1 is redox-dependent in barrett\u2019s related esophageal adenocarcinoma cells. Redox Biol Jul. 43, 101970. https:\/\/doi.org\/10.1016\/j.redox.2021.101970 (2021).","journal-title":"Redox Biol Jul"},{"issue":"1","key":"37428_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1874467211205010036","volume":"5","author":"MR Kelley","year":"2012","unstructured":"Kelley, M. R., Georgiadis, M. M. & Fishel, M. L. APE1\/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair\/redox protein APE1\/Ref-1. Curr Mol. Pharmacol Jan. 5 (1), 36\u201353. https:\/\/doi.org\/10.2174\/1874467211205010036 (2012).","journal-title":"Curr Mol. Pharmacol Jan"},{"key":"37428_CR62","doi-asserted-by":"publisher","first-page":"895729","DOI":"10.3389\/fendo.2022.895729","volume":"13","author":"SA Jeffreys","year":"2022","unstructured":"Jeffreys, S. A. et al. Prognostic and predictive value of CCND1\/Cyclin D1 amplification in breast cancer with a focus on postmenopausal patients: A systematic review and Meta-Analysis. Front. Endocrinol. (Lausanne). 13, 895729. https:\/\/doi.org\/10.3389\/fendo.2022.895729 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"37428_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/cvr\/cvae243","volume":"15","author":"G Senesi","year":"2025","unstructured":"Senesi, G. et al. miR-24-3p secreted as extracellular vesicle cargo by cardiomyocytes inhibits fibrosis in human cardiac microtissues. Cardiovasc Res Apr. 15 (1), 143\u2013156. https:\/\/doi.org\/10.1093\/cvr\/cvae243 (2025).","journal-title":"Cardiovasc Res Apr"},{"issue":"1","key":"37428_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s43044-025-00628-0","volume":"10","author":"SS Tanwar","year":"2025","unstructured":"Tanwar, S. S., Dwivedi, S., Khan, S. & Sharma, S. Cardiomyopathies and a brief insight into DOX-induced cardiomyopathy. Egypt Heart J Mar. 10 (1), 29. https:\/\/doi.org\/10.1186\/s43044-025-00628-0 (2025).","journal-title":"Egypt Heart J Mar."},{"issue":"8","key":"37428_CR65","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.21037\/jtd-24-927","volume":"31","author":"J Zheng","year":"2024","unstructured":"Zheng, J. et al. N-acetylcysteine, a small molecule scavenger of reactive oxygen species, alleviates cardiomyocyte damage by regulating OPA1-mediated mitochondrial quality control and apoptosis in response to oxidative stress. J Thorac. Dis Aug. 31 (8), 5323\u20135336. https:\/\/doi.org\/10.21037\/jtd-24-927 (2024).","journal-title":"J Thorac. Dis Aug"},{"issue":"7","key":"37428_CR66","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1007\/s12035-015-9415-8","volume":"53","author":"CC Zhang","year":"2016","unstructured":"Zhang, C. C., Xing, A., Tan, M. S., Tan, L. & Yu, J. T. The role of MAPT in neurodegenerative diseases: Genetics, mechanisms and therapy. Mol Neurobiol Sep. 53 (7), 4893\u20134904. https:\/\/doi.org\/10.1007\/s12035-015-9415-8 (2016).","journal-title":"Mol Neurobiol Sep."},{"issue":"8","key":"37428_CR67","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.4103\/1673-5374.332125","volume":"17","author":"AK Torres","year":"2022","unstructured":"Torres, A. K., Rivera, B. I., Polanco, C. M., Jara, C. & Tapia-Rojas, C. Phosphorylated Tau as a toxic agent in synaptic mitochondria: implications in aging and alzheimer\u2019s disease. Neural Regen Res Aug. 17 (8), 1645\u20131651. https:\/\/doi.org\/10.4103\/1673-5374.332125 (2022).","journal-title":"Neural Regen Res Aug"},{"issue":"3","key":"37428_CR68","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/ERC-17-0483","volume":"25","author":"Y Zhou","year":"2018","unstructured":"Zhou, Y. et al. Sulforaphane metabolites cause apoptosis via microtubule disruption in cancer. Endocr Relat. Cancer Mar. 25 (3), 255\u2013268. https:\/\/doi.org\/10.1530\/ERC-17-0483 (2018).","journal-title":"Endocr Relat. Cancer Mar."},{"issue":"11","key":"37428_CR69","doi-asserted-by":"publisher","first-page":"e00199","DOI":"10.1128\/MCB.00199-17","volume":"1","author":"AL Kullas","year":"2017","unstructured":"Kullas, A. L. & Davis, R. J. Setting the (Scientific) record straight: molecular and cellular biology responds to postpublication review. Mol Cell. Biol Jun. 1 (11), e00199\u2013e00117. https:\/\/doi.org\/10.1128\/MCB.00199-17 (2017).","journal-title":"Mol Cell. Biol Jun"},{"issue":"21","key":"37428_CR70","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1158\/0008-5472.CAN-05-1095","volume":"1","author":"MR Albertella","year":"2005","unstructured":"Albertella, M. R., Green, C. M., Lehmann, A. R. & O\u2019Connor, M. J. A role for polymerase Eta in the cellular tolerance to cisplatin-induced damage. Cancer Res Nov. 1 (21), 9799\u20139806. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1095 (2005).","journal-title":"Cancer Res Nov"},{"issue":"6","key":"37428_CR71","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia, Y. et al. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol. Cell. Cardiol Jun. 52 (6), 1213\u20131225. https:\/\/doi.org\/10.1016\/j.yjmcc.2012.03.006 (2012).","journal-title":"J Mol. Cell. Cardiol Jun"},{"issue":"11","key":"37428_CR72","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.bcp.2008.02.029","volume":"1","author":"HY Yoon","year":"2008","unstructured":"Yoon, H. Y. et al. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol Jun. 1 (11), 2214\u20132223. https:\/\/doi.org\/10.1016\/j.bcp.2008.02.029 (2008).","journal-title":"Biochem Pharmacol Jun"},{"key":"37428_CR73","doi-asserted-by":"publisher","unstructured":"Song, C., Huang, L., Li, D. & Zhao, X. Artemisinin Alleviates Alcohol-Induced Cardiotoxicity by Inhibiting Ferroptosis via the Nrf2\/NQO1 Pathway In Vivo and In Vitro. J Agric Food Chem. May 28. ;73(21):12940\u201312948. (2025). https:\/\/doi.org\/10.1021\/acs.jafc.4c08388","DOI":"10.1021\/acs.jafc.4c08388"},{"issue":"12","key":"37428_CR74","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.exger.2012.09.003","volume":"47","author":"T Ramesh","year":"2012","unstructured":"Ramesh, T. et al. Cordycepin (3\u2019-deoxyadenosine) attenuates age-related oxidative stress and ameliorates antioxidant capacity in rats. Exp Gerontol Dec. 47 (12), 979\u2013987. https:\/\/doi.org\/10.1016\/j.exger.2012.09.003 (2012).","journal-title":"Exp Gerontol Dec."},{"key":"37428_CR75","doi-asserted-by":"publisher","first-page":"176951","DOI":"10.1016\/j.ejphar.2024.176951","volume":"5","author":"D Chen","year":"2024","unstructured":"Chen, D. et al. Network Pharmacology and experimental validation to reveal the Pharmacological mechanisms of Astragaloside \u2163 in treating intervertebral disc degeneration. Eur J. Pharmacol Nov. 5, 982:176951. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176951 (2024).","journal-title":"Eur J. Pharmacol Nov"},{"issue":"5","key":"37428_CR76","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ijc.20880","volume":"20","author":"X Wang","year":"2005","unstructured":"Wang, X. et al. Potential anticancer activity of Tanshinone IIA against human breast cancer. Int J. Cancer Sep. 20 (5), 799\u2013807. https:\/\/doi.org\/10.1002\/ijc.20880 (2005).","journal-title":"Int J. Cancer Sep."},{"issue":"12","key":"37428_CR77","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1080\/02713683.2017.1355467","volume":"42","author":"RM Alzhrani","year":"2017","unstructured":"Alzhrani, R. M. et al. Tanshinone IIA inhibits VEGF secretion and HIF-1alpha expression in cultured human retinal pigment epithelial cells under hypoxia. Curr Eye Res Dec. 42 (12), 1667\u20131673. https:\/\/doi.org\/10.1080\/02713683.2017.1355467 (2017).","journal-title":"Curr Eye Res Dec."},{"key":"37428_CR78","doi-asserted-by":"publisher","first-page":"8371623","DOI":"10.1155\/2023\/8371623","volume":"2023","author":"Y He","year":"2023","unstructured":"He, Y. et al. Tanshinone IIA inhibits Triple-Negative breast cancer cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) dependent signaling pathway. Dis. Markers. 2023, 8371623. https:\/\/doi.org\/10.1155\/2023\/8371623 (2023).","journal-title":"Dis. Markers"},{"issue":"2","key":"37428_CR79","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3892\/ijo.2014.2471","volume":"45","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Tanshinone IIA induces cytochrome c-mediated caspase cascade apoptosis in A549 human lung cancer cells via the JNK pathway. Int J. Oncol Aug. 45 (2), 683\u2013690. https:\/\/doi.org\/10.3892\/ijo.2014.2471 (2014).","journal-title":"Int J. Oncol Aug"},{"issue":"19","key":"37428_CR80","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.3390\/cancers13194798","volume":"25","author":"LEL Terceiro","year":"2021","unstructured":"Terceiro, L. E. L. et al. The breast tumor microenvironment: A key player in metastatic spread. Cancers (Basel) Sep. 25 (19), 4798. https:\/\/doi.org\/10.3390\/cancers13194798 (2021).","journal-title":"Cancers (Basel) Sep."},{"issue":"5","key":"37428_CR81","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"4","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell Mar. 4 (5), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell Mar."},{"issue":"8","key":"37428_CR82","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/ph18081140","volume":"31","author":"M Zhra","year":"2025","unstructured":"Zhra, M., Holail, J. H. & Mohammad, K. S. Epigenetic modulation and bone metastasis: evolving therapeutic strategies. Pharmaceuticals (Basel) Jul. 31 (8), 1140. https:\/\/doi.org\/10.3390\/ph18081140 (2025).","journal-title":"Pharmaceuticals (Basel) Jul"},{"issue":"2","key":"37428_CR83","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-016-3743-x","volume":"156","author":"H Matsumoto","year":"2016","unstructured":"Matsumoto, H. et al. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res. Treat Apr. 156 (2), 237\u2013247. https:\/\/doi.org\/10.1007\/s10549-016-3743-x (2016).","journal-title":"Breast Cancer Res. Treat Apr"},{"issue":"1","key":"37428_CR84","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1186\/s12885-024-12916-0","volume":"17","author":"A Zuo","year":"2024","unstructured":"Zuo, A. et al. High ratio of resident to exhausted CD4\u2009+\u2009T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinoma. BMC Cancer Sep. 17 (1), 1152. https:\/\/doi.org\/10.1186\/s12885-024-12916-0 (2024).","journal-title":"BMC Cancer Sep."},{"issue":"8","key":"37428_CR85","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/annonc\/mdu112","volume":"25","author":"S Loi","year":"2014","unstructured":"Loi, S. et al. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Ann Oncol Aug. 25 (8), 1544\u20131550. https:\/\/doi.org\/10.1093\/annonc\/mdu112 (2014).","journal-title":"Ann Oncol Aug"},{"key":"37428_CR86","doi-asserted-by":"publisher","first-page":"175883592110646","DOI":"10.1177\/17588359211064653","volume":"13","author":"M Santisteban","year":"2021","unstructured":"Santisteban, M. et al. Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis. Ther. Adv. Med. Oncol. 13, 17588359211064653. https:\/\/doi.org\/10.1177\/17588359211064653 (2021).","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"3","key":"37428_CR87","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"8","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell Sep. 8 (3), 183\u2013194. https:\/\/doi.org\/10.1016\/j.ccr.2009.06.017 (2009).","journal-title":"Cancer Cell Sep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37428-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37428-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37428-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T11:34:07Z","timestamp":1771414447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37428-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37428"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37428-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study has not yet conducted human or animal experiments and therefore does not require the signing of informed consent forms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}],"article-number":"6861"}}